AlphaYouMP
Insider selling
Matthew Pauls sold $17K of Pelthos Therapeutics Inc. (PTHS) stock
Matthew Pauls, Dir of Pelthos Therapeutics Inc. (PTHS), sold 786 shares of PTHS stock worth $17K, per an SEC Form 4 filed Oct 6, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 2, 2026, 4 days before it was made public.
PTHS has moved +4.3% since the trade date, from $20.60 to $21.48 (Oct 6, 2026 close).
- Traded
- Oct 2, 2026
- Disclosed
- Oct 6, 2026
- Filing delay
- 4 days
- Price since
- +4.3%
- Role
- Dir
- Source
- SEC Form 4
More PTHS insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.